GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $180,000 | 0.0% | 4,124 | 0.0% | 0.01% | +8.3% |
| Q1 2022 | $180,000 | -1.1% | 4,124 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $182,000 | +80.2% | 4,124 | +56.6% | 0.01% | +57.1% |
| Q3 2021 | $101,000 | -2.9% | 2,634 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $104,000 | +10.6% | 2,634 | 0.0% | 0.01% | +16.7% |
| Q1 2021 | $94,000 | -3.1% | 2,634 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $97,000 | -19.2% | 2,634 | -17.3% | 0.01% | -30.0% |
| Q3 2020 | $120,000 | -7.7% | 3,186 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $130,000 | +7.4% | 3,186 | 0.0% | 0.01% | -7.7% |
| Q1 2020 | $121,000 | +18.6% | 3,186 | +46.4% | 0.01% | +44.4% |
| Q4 2019 | $102,000 | +10.9% | 2,176 | +1.9% | 0.01% | 0.0% |
| Q3 2019 | $92,000 | +7.0% | 2,136 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $86,000 | -3.4% | 2,136 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $89,000 | +8.5% | 2,136 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $82,000 | -4.7% | 2,136 | 0.0% | 0.01% | +11.1% |
| Q3 2018 | $86,000 | 0.0% | 2,136 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $86,000 | +3.6% | 2,136 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $83,000 | -24.5% | 2,136 | -31.3% | 0.01% | -23.1% |
| Q4 2017 | $110,000 | +13.4% | 3,111 | +30.1% | 0.01% | 0.0% |
| Q3 2017 | $97,000 | -5.8% | 2,391 | 0.0% | 0.01% | -13.3% |
| Q2 2017 | $103,000 | +3.0% | 2,391 | 0.0% | 0.02% | -6.2% |
| Q1 2017 | $100,000 | +6.4% | 2,391 | -1.6% | 0.02% | 0.0% |
| Q4 2016 | $94,000 | -10.5% | 2,430 | 0.0% | 0.02% | -15.8% |
| Q3 2016 | $105,000 | +7.1% | 2,430 | +7.0% | 0.02% | +5.6% |
| Q2 2016 | $98,000 | +6.5% | 2,270 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $92,000 | 0.0% | 2,270 | 0.0% | 0.02% | -5.3% |
| Q4 2015 | $92,000 | -16.4% | 2,270 | -20.9% | 0.02% | -17.4% |
| Q3 2015 | $110,000 | +15.8% | 2,870 | +25.4% | 0.02% | +21.1% |
| Q2 2015 | $95,000 | -10.4% | 2,288 | 0.0% | 0.02% | -9.5% |
| Q1 2015 | $106,000 | +26.2% | 2,288 | +17.0% | 0.02% | +23.5% |
| Q4 2014 | $84,000 | -43.6% | 1,956 | -39.6% | 0.02% | -43.3% |
| Q3 2014 | $149,000 | -19.5% | 3,239 | -6.2% | 0.03% | -16.7% |
| Q2 2014 | $185,000 | 0.0% | 3,454 | 0.0% | 0.04% | -2.7% |
| Q1 2014 | $185,000 | +0.5% | 3,454 | 0.0% | 0.04% | 0.0% |
| Q4 2013 | $184,000 | +9.5% | 3,454 | +3.0% | 0.04% | -2.6% |
| Q3 2013 | $168,000 | -2.9% | 3,354 | -3.1% | 0.04% | -7.3% |
| Q2 2013 | $173,000 | – | 3,460 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |